Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by Pinto Alexis, Directeur Juridique. Officer active across 1 company, notably Zentalis Pharmaceuticals, Inc.. Aggregated, 2 disclosures have been published. Activity tracked since 25 October 2021. The latest transaction was filed on 10 February 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Alexis Pinto is the Chief Legal Officer of Zentalis Pharmaceuticals, Inc. She oversees the legal affairs of the company, ensuring regulatory compliance and protecting the interests of the organization in the pharmaceutical sector.